Medical Condition News

RSS

Late-life depression could become major risk factor for developing Alzheimer's

Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer's disease.

10 Jun 2014

Combination of novel molecular imaging techniques can help predict spread of cancer, patient survival

A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients' chances of survival, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

10 Jun 2014

JDRF-funded researchers find that beta cell stress may play vital role in the onset of type 1 diabetes

In the healthy pancreas of someone without type 1 diabetes (T1D), the hormone insulin (essential for turning food into energy) is produced, stored, and released in a normal "factory-like" process within pancreatic beta cells in response to glucose in the diet.

10 Jun 2014

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Researchers at the Center of Excellence in Environmental Toxicology, Perelman School of Medicine at the University of Pennsylvania, have been awarded a $10 million grant from the National Institute for Environmental Health Sciences over the next four years to study asbestos exposure pathways that lead to mesothelioma, the bioremediation of this hazardous material, and mechanisms that lead to asbestos-related diseases.

10 Jun 2014

Contacta to manufacture HLD large area hearing loop product platform in the USA

Contacta Inc. has today announced the HLD large area hearing loop product platform will be manufactured in the USA.

9 Jun 2014

Itamar Medical's leading sleep apnea diagnostic device receives FDA clearance

Itamar Medical reported today, June 9th, 2014, that the new and upgraded model of the WatchPAT, Itamar Medical's leading sleep apnea diagnostic device, has been cleared by the FDA.

9 Jun 2014

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-DMPKRx. Isis earned a $14 million milestone payment from Biogen Idec associated with this achievement.

9 Jun 2014

International leaders redefine phenotypes of multiple sclerosis

Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions - or phenotypes -- of MS was undertaken by an international team of leaders in MS research and clinical care.

9 Jun 2014

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

Pharmacyclics, Inc. today announced that the U.S. Food and Drug Administration has accepted for filing its supplemental New Drug Application (sNDA) to support the review of IMBRUVICA (ibrutinib) in the treatment of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who have received at least one prior therapy for a full approval.

9 Jun 2014

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).

9 Jun 2014

Virtual reality can be effective adjunct for chronic and acute pain conditions

Chronic pain due to disease or injury is common, and even prescription pain medications cannot provide acceptable pain relief for many individuals.

9 Jun 2014

Tough driving laws reduce speeding-related fatalities among young men, shows study

A new study out of Western University (London, Canada) has found a significant decline in speeding-related fatalities and injuries among young men in Ontario since the province's tough extreme speeding and aggressive driving laws were introduced in 2007.

9 Jun 2014

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

As part of its ongoing research to better understand the complexities of the human brain, the Allen Institute for Brain Science is embarking on the first effort to map connectivity patterns across the whole brain in mouse models of Alzheimer's disease, through its recent award of a $3.4 million grant over five years from the National Institute on Aging of the National Institutes of Health.

9 Jun 2014

Certain molecules in seminal fluid indicate presence and severity of prostate cancer

Improved diagnosis and management of one of the most common cancers in men - prostate cancer - could result from research at the research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.

9 Jun 2014

Banner Health receives prestigious stroke award

Several Banner Health facilities in Arizona have received a prestigious stroke award in recognition of their ability to better diagnose and treat stroke patients, to reduce death and disability among patients and to speed recovery.

9 Jun 2014

UAB ophthalmologists offer tips to prevent firework related injuries

Fourth of July 2013: Family members were shooting fireworks in the backyard of Dianne Peterson's home in Vincent, Alabama, as she walked out of the house.

9 Jun 2014

Research finding paves way for targeted approaches to treating cancer patients

Twelve years ago, UNC School of Medicine researcher Brian Strahl, PhD, found that a protein called Set2 plays a role in how yeast genes are expressed - specifically how DNA gets transcribed into messenger RNA. Now his lab has found that Set2 is also a major player in DNA repair, a complicated and crucial process that can lead to the development of cancer cells if the repair goes wrong.

9 Jun 2014

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.

9 Jun 2014

Actinium's Chairman to discuss role of alpha-particle radiopharmaceuticals at SNMMI Annual Meeting

Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Actinium's Clinical Advisory Board Chairman Joseph Jurcic, MD will participate in an upcoming panel discussion highlighting the role of Actinium's alpha-particle radiopharmaceuticals in the treatment of leukemia patients.

9 Jun 2014

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.

9 Jun 2014

Medical Condition News

Late-life depression could become major risk factor for developing Alzheimer's

Combination of novel molecular imaging techniques can help predict spread of cancer, patient survival

JDRF-funded researchers find that beta cell stress may play vital role in the onset of type 1 diabetes

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Contacta to manufacture HLD large area hearing loop product platform in the USA

Itamar Medical's leading sleep apnea diagnostic device receives FDA clearance

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

International leaders redefine phenotypes of multiple sclerosis

FDA accepts Pharmacyclics' IMBRUVICA sNDA for review

Antiviral therapy may prevent hepatitis B virus from developing into hepatocellular carcinoma

Virtual reality can be effective adjunct for chronic and acute pain conditions

Tough driving laws reduce speeding-related fatalities among young men, shows study

National Institutes of Health awards $3.4M grant for Alzheimer's disease research

Certain molecules in seminal fluid indicate presence and severity of prostate cancer

Banner Health receives prestigious stroke award

UAB ophthalmologists offer tips to prevent firework related injuries

Research finding paves way for targeted approaches to treating cancer patients

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Actinium's Chairman to discuss role of alpha-particle radiopharmaceuticals at SNMMI Annual Meeting

Advances in understanding of genetics of CAD lead to more therapeutic targets

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News